Natera
Natera, Inc., a leading genetic testing company headquartered in the United States, has been at the forefront of the genomics industry since its founding in 2004. With a strong presence in North America and expanding operations globally, Natera focuses on reproductive health, oncology, and organ transplantation. The company is renowned for its innovative non-invasive prenatal testing (NIPT) and advanced cancer diagnostics, which leverage cutting-edge technology to provide accurate and actionable insights. Natera's unique approach to genetic testing has positioned it as a trusted partner in healthcare, with significant milestones including the launch of its flagship product, Panorama, which revolutionised prenatal screening. With a commitment to improving patient outcomes, Natera continues to achieve notable recognition in the market, solidifying its status as a pioneer in the field of genetic testing.
DitchCarbon Score
How does Natera's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Natera's score of 43 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Natera's reported carbon emissions
In 2023, Natera reported total carbon emissions of approximately 154,029,510 kg CO2e. This figure includes 4,597,760 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 3,109,150 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The majority of their emissions, about 146,322,600 kg CO2e, fall under Scope 3, which includes all other indirect emissions in the value chain, such as purchased goods and services, business travel, and employee commuting. In comparison, Natera's 2022 emissions were reported at approximately 113,327,000 kg CO2e in the US, with Scope 1 emissions at 6,826,000 kg CO2e, Scope 2 at 3,546,000 kg CO2e, and Scope 3 at 102,955,000 kg CO2e. The global figures for 2022 showed total emissions of about 140,997,250 kg CO2e, with similar distributions across the scopes. Natera has committed to near-term climate targets, although specific reduction targets have not been disclosed. The company is actively engaged in sustainability initiatives within the healthcare sector, aiming to reduce its carbon footprint and enhance its environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 6,004,700 | 0,000,000 | 0,000,000 |
| Scope 2 | 2,660,810 | 0,000,000 | 0,000,000 |
| Scope 3 | 87,380,350 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Natera is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
